Literature DB >> 19566543

Biological variation in inflammatory and hemostatic markers.

G Rudez1, P Meijer, H M H Spronk, F W G Leebeek, H ten Cate, C Kluft, M P M de Maat.   

Abstract

BACKGROUND: Concentrations of inflammatory and hemostatic variables are influenced by biological variation, which is the natural within-subject variation over time.
OBJECTIVES: The aim of this study was to determine fibrinogen, C-reactive protein (CRP), platelet aggregation, thrombin generation and prothrombin time (PT): (i) the number of repeated measurements needed to obtain the true habitual concentration of an individual; (ii) the recommended analytical imprecision for diagnosis and monitoring; (iii) the recommended analytical bias; (iv) the contribution of analytical imprecision to test result variability; (v) the index of individuality; (vi) the reference change value; and (vii) the seasonal variation. SUBJECTS AND METHODS: We collected 520 blood samples over a 1-year period from 40 healthy individuals, and determined the between-subject, within-subject and seasonal variation in fibrinogen, CRP, platelet aggregation, thrombin generation and PT.
RESULTS: One or two repeated measurements were sufficient to establish the true habitual concentration, except for platelet aggregation and peak thrombin generation, where at least four and nine repeated measurements were needed, respectively. For diagnosis, the maximal recommended coefficient of analytical variation (CV) was 4%-27%, except for CRP (77.7%). For monitoring, these CVs were on average 3% lower. Recommended analytical bias varied between 1.7% and 33.2%. Finally, seasonal variation was observed in concentrations of fibrinogen and thrombin generation, which could explain approximately 11% of their total variation.
CONCLUSION: This study provides insights into the biological variability of selected inflammatory and hemostatic markers, which can be used for sample size calculations and to determine the analytical quality specifications for their respective assays.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566543     DOI: 10.1111/j.1538-7836.2009.03488.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  10 in total

Review 1.  Introduction to haemostasis from a pharmacodynamic perspective.

Authors:  Cornelis Kluft; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

2.  Endurance training modifies exercise-induced activation of blood coagulation: RCT.

Authors:  Thomas Hilberg; Kathleen Menzel; Udo F Wehmeier
Journal:  Eur J Appl Physiol       Date:  2012-12-13       Impact factor: 3.078

3.  Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures.

Authors:  Niels Lech Pedersen; Mathias Mertz Petersen; Jon J Ladd; Paul D Lampe; Robert S Bresalier; Gerard J Davis; Christina Demuth; Sarah Ø Jensen; Claus L Andersen; Linnea Ferm; Ib J Christensen; Hans J Nielsen
Journal:  Clin Chim Acta       Date:  2020-04-06       Impact factor: 3.786

4.  Effects of age and season on haematological parameters of donkeys during the rainy and cold-dry seasons.

Authors:  Friday Ocheja Zakari; Joseph Olusegun Ayo; Peter Ibrahim Rekwot; Mohammed Umar Kawu
Journal:  Int J Biometeorol       Date:  2015-04-10       Impact factor: 3.787

5.  Repeating tests: different roles in research studies and clinical medicine.

Authors:  Paul A Monach
Journal:  Biomark Med       Date:  2012-10       Impact factor: 2.851

6.  Seasonal variation of overall and cardiovascular mortality: a study in 19 countries from different geographic locations.

Authors:  Helena Marti-Soler; Semira Gonseth; Cédric Gubelmann; Silvia Stringhini; Pascal Bovet; Pau-Chung Chen; Bogdan Wojtyniak; Fred Paccaud; Dai-Hua Tsai; Tomasz Zdrojewski; Pedro Marques-Vidal
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

7.  Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation.

Authors:  Tracy Stokol; Priscila Beatriz da Silva Serpa; Muhammad N Zahid; Marjory B Brooks
Journal:  Front Vet Sci       Date:  2016-11-17

8.  Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease.

Authors:  Siddhee A Sahasrabudhe; Marcia R Terluk; Kyle D Rudser; James C Cloyd; Reena V Kartha
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

9.  Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test.

Authors:  Dana Huskens; Yaqiu Sang; Joke Konings; Lisa van der Vorm; Bas de Laat; Hilde Kelchtermans; Mark Roest
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

10.  Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation.

Authors:  Tracy Stokol; Priscila B S Serpa; Marjory B Brooks; Thomas Divers; Sally Ness
Journal:  Front Vet Sci       Date:  2018-05-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.